Tonix Pharmaceuticals Holding Corp TNXP
$12.55 $0.16 (1.29%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
TNXP Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Tonix Pharmaceuticals Holding Corp is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Tonix Pharmaceuticals Holding Corp. Stock Analysis TNXP
United States Health Care Micro Cap Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. The company is headquartered in Chatham, New Jersey and currently employs 142 full-time employees. The company went IPO on 2010-03-29. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. The company markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Tonix Pharmaceuticals Holding Corp (TNXP) Chart
Financial Metrics & Statements of Tonix Pharmaceuticals Holding Corp (TNXP)
FAQ's for Tonix Pharmaceuticals Holding Corp (TNXP)
- As of August 2026, Tonix Pharmaceuticals Holding Corp TNXP is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Tonix Pharmaceuticals Holding Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Tonix Pharmaceuticals Holding Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Tonix Pharmaceuticals Holding Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Tonix Pharmaceuticals Holding Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Tonix Pharmaceuticals Holding Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Tonix Pharmaceuticals Holding Corp (TNXP)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
